1. Home
  2. STEM vs ATNM Comparison

STEM vs ATNM Comparison

Compare STEM & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stem Inc.

STEM

Stem Inc.

N/A

Current Price

$2.17

Market Cap

34.6M

Sector

Technology

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.47

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STEM
ATNM
Founded
2009
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
31.4M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
STEM
ATNM
Price
$2.17
$1.47
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
★ $6.25
$4.00
AVG Volume (30 Days)
158.5K
★ 233.4K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 14.17
EPS
N/A
★ 0.71
Revenue
★ $156,266,000.00
$90,000.00
Revenue This Year
N/A
$38,788.89
Revenue Next Year
$15.96
N/A
P/E Ratio
★ N/A
$2.14
Revenue Growth
8.08
★ 11.11
52 Week Low
$2.35
$0.74
52 Week High
$22.12
$1.72

Technical Indicators

Market Signals
Indicator
STEM
ATNM
Relative Strength Index (RSI) 19.90 61.79
Support Level N/A $0.91
Resistance Level $6.02 $1.66
Average True Range (ATR) 0.30 0.14
MACD -0.10 0.02
Stochastic Oscillator 0.00 74.65

Price Performance

Historical Comparison
STEM
ATNM

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: